Clinical Trials
63 trialsVaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer
University of Washington
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Memorial Sloan Kettering Cancer Center
SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Canadian Cancer Trials Group
Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer
City of Hope Medical Center
White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy
City of Hope Medical Center
Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496
Eastern Cooperative Oncology Group
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
Abramson Cancer Center at Penn Medicine
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer
University of Washington
DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia
Eastern Cooperative Oncology Group
Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment
Abramson Cancer Center at Penn Medicine
Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma
Mayo Clinic
Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer
Mayo Clinic
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
Wake Forest University Health Sciences
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery
Fox Chase Cancer Center
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
University of Washington
Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
Mayo Clinic
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases
Fred Hutchinson Cancer Center
Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab
Eastern Cooperative Oncology Group
Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia
Eastern Cooperative Oncology Group
Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim
Eastern Cooperative Oncology Group
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
University of Louisville
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Fred Hutchinson Cancer Center
Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors
University of California, San Francisco
Study of Proteins in Head and Neck Cancer Cells
Vanderbilt University Medical Center
DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx
Vanderbilt University Medical Center
Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Roswell Park Cancer Institute
Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2
Alliance for Clinical Trials in Oncology
Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer
Alliance for Clinical Trials in Oncology
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
Children's Oncology Group
Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202
Vanderbilt-Ingram Cancer Center
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
National Cancer Institute (NCI)
Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
Case Comprehensive Cancer Center
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
Case Comprehensive Cancer Center
Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss
Case Comprehensive Cancer Center
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
Case Comprehensive Cancer Center
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
City of Hope Medical Center
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial
NSABP Foundation Inc
Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin
National Cancer Institute (NCI)
S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia
SWOG Cancer Research Network
A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies
Fred Hutchinson Cancer Center
Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma
Cancer Trials Ireland
Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma
Fred Hutchinson Cancer Center
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
National Cancer Institute (NCI)
Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
National Cancer Institute (NCI)
Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
National Cancer Institute (NCI)
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
National Cancer Institute (NCI)